For Physicians and Healthcare Providers

This page contains information specifically for physicians and other healthcare providers who diagnose and treat women with female sexual dysfunction. Female Sexual Dysfunction continues to gain recognition and awareness among physicians and women as a true medical condition.

Scientific Meetings & Conferences

Learn more about treating female sexual dysfunction by visiting UroMetrics at the following scientific meetings and conferences.

American College of Obstetricians and Gynecologists (ACOG)
Annual Clinical Meeting
New Orleans April 25-30, 2003

• For FSFF membership information, please email Dr. Mitchel Tepper at mitch@sexualhealth.com.

Eros Therapy™ — Prescription Information

• The Eros Therapy is the first cleared-to-market treatment for Female Sexual Dysfunction. Click for Eros Therapy Prescription Information.

Eros Therapy™ Clinical Studies

• A Non-Pharmacological Method to Increase Vaginal Blood Flow in Patients with Sexual Arousal Disorder.
  Rachel N. Pauls, MD; Laura Berman, PhD; Jennifer Berman, MD; Los Angeles, CA
   
  The goal of this pilot study was to determine effects of the Eros Therapy on vaginal blood flow. Click for study results.
   
• A Prospective Duplex Doppler Ultrasonographic Study in Women with Sexual Arousal Disorder to Objectively Assess Genital Engorgement Following Therapeutic Use with the Eros Therapy.
  Ricardo Munarriz, Lily Talakoub, Irwin Goldstein; Boston University, Boston, MA
   
  The aim of this prospective, IRB-approved study was to obtain objective information regarding the effectiveness of the Eros Therapy to increase genital blood flow to the clitoris following therapeutic use in women with sexual arousal disorder. Click for study results.
   
• Initial Clinical Study
  Kevin Billups, M.D., Billups Institute for Sexual Health & Medicine, St. Paul, MN
  Irwin Goldstein, M.D., Boston University, Boston, MA
   
  The objective of this 32-subject study was to determine whether use of the Eros Therapy improved sexual arousal. Click for Study Results.
    
• Follow-Up Study
  Steve Wilson, M.D. and Barbara Wilson, Wilson Urology, Van Buren, AR
   
  Nineteen subjects were enrolled in this study, 10 with symptoms of female sexual dysfunction and 9 without female sexual dysfunction. Click for Study Results.
   
• On-Going Clinical Studies

Principal Investigators	Location	Objective
Kevin Billups, M.D. Irwin Goldstein, M.D.	St. Paul Boston	Evaluate the effectiveness of the Eros Therapy in improving symptoms of FSD in diabetic women.
A.J. Mundt, M.D. Maryann Schroder, Ph.D.	Chicago	Evaluate the effectiveness of the Eros Therapy in treating women who have undergone surgical procedures and radiation therapy to treat cervical cancer.
Eric Bieber, M.D. Maryann Schroder, Ph.D.	Chicago	Evaluate the effectiveness of the Eros Therapy in treating post-menopausal women with symptoms of female sexual dysfunction.